C-Section pain pump put to the test: could it cut opioid need?
NCT ID NCT05131178
First seen Feb 06, 2026 · Last updated Jun 19, 2026 · Updated 15 times
Summary
This study looks at whether a continuous pain pump delivering bupivacaine (a numbing medicine) after a C-section reduces the need for stronger opioid painkillers compared to a placebo pump with salt water. One hundred pregnant women having C-sections will be randomly assigned to receive either the active drug or placebo through the pump for up to four days. The goal is to see if the bupivacaine pump alone is responsible for lower opioid use, helping improve recovery after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-OPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80011, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If it works, this could confirm that the bupivacaine pump is what reduces opioid use after C-sections, helping guide standard pain management.
What could go wrong
This is a small, early-stage trial with only 100 participants, so results may not apply to all patients. The placebo group also gets standard care, so the difference might be small.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.